Summary

Darou Darman Arang is a fast growing pharmaceutical Company in Iran.

Our Story

We are a fast growing pharmaceutical company manufacturing our own brands and representing  pharmaceutical companies from around the world in Iran to import medicines.

DAROU DARMAN ARANG acts as the representative agent for specialty, rare disease, biotech and vaccine producing companies looking to penetrate to Iran. We are the preferred strategic partner, providing turn-key solutions and support for their commercial operations……  Read more 

 

Manufacturing

We have ensured world-class quality in design, equipment and operations in our manufacturing facility. Our units ensure that we are able to provide best-in-class products to patients across the Iran and emerging markets around. Our manufacturing operations are focused on producing generics and branded generics, in the full range of dosage forms, including tablets, capsules, injectable, pre-filled syringe and freeze dried powder. ……  Read more 

 

Imports of Finished Pharmaceuticals

As the pioneer of our mission to meet the needs of the health society across IRAN and beyond with our expert staffs and facilities to import different health care products…… Read more 

Summary

Research & Development Department

We in R&D department aimed to Reach to various market requirements and high quality products, by representing formulation and providing new method analysis, taking advantage of experienced Experts, using the most up to dated sources of pharmaceuticals and advanced devices. In addition to exploitation of cooperation and consultation of prominent University professors and other authentic science centers.

Read More

Activities

Regulatory

Having sufficient knowledge of drug registration rules & regulations for registration of products
Adequately capability of registering new products in the Drug National List
Well knowledge of the drug, raw material and food supplement approval process and registration bureaucracy in Ministry of Health
Submitting registration documents to MOH

Read More

DAROU DARMAN ARANG COMPANY WAS ESTABLISHED BY A GROUP OF EXPERIENCED PEOPLE TO ATTRACT, DEVELOP AND DELIVER NEW CAPABILITIES.

Featured products

Latest news

[ News Archive ]

22 May

EMA recommends approval of bevacizumab Lytenava

<p>On 21 March 2024, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorization&nbsp;(MA)&nbsp;for Outlook Therapeutics’ Lytenava (ONS-5010, bevacizumab gamma),&nbsp;intended for treatment of neovascular (wet) age-related macular degeneration (nAMD).</p>

22 May

MHRA unveils strategy for regulating AI technologies

<p>In April 2024, the&nbsp;UK’s&nbsp;Medicines and Healthcare products Regulatory Agency (MHRA) published a policy paper on its strategic approach to artificial intelligence (AI) [1]. It summarises the MHRA’s view on the UK government’s white paper on AI regulation published in 2023 [2] and is the agency’s response to the Secretary of State letter of 1 February 2024 [3].</p>

22 May

Saudi FDA drug approvals and GMP inspections: trend analysis

<p>A&nbsp;GaBIJ Review Article&nbsp;entitled ‘Trends in Saudi FDA drug approvals and GMP inspections: an observational study’, was published by a group of authors,&nbsp;<i>Alhomaidan et al.,</i>&nbsp;from&nbsp;Saudi Food and Drug Authority (SFDA)&nbsp;in October 2023 [1].</p>

Copyright © 2024 Darou Darman Arang Co. All rights reserved.